【摘 要】
：
In this study, a novel fast dissolving film containing drug nanoparticles was developed with the goal of transforming drug nanosuspensions into a solid dosage.Nanosuspensions were prepared by high pre
【机 构】
：
302 Hospital of PLA&PLA Institute of Chinese Materia Medica,Beijing 100039,China
【出 处】
：
2013年“好医生杯”中药制剂创新与发展论坛
论文部分内容阅读
In this study, a novel fast dissolving film containing drug nanoparticles was developed with the goal of transforming drug nanosuspensions into a solid dosage.Nanosuspensions were prepared by high pressure homogenization and then transformed into fast dissolving film containing drug nanoparticles by film casting.Herpetrione (HPE), a novel and potent antiviral agent with poor water solubility that extracted from Herpetospermum caudigerum, was chosen as a model drug and studied systematically.The uniformity of dosage units of the preparation was acceptable according to the criteria of Chinese Pharmacopoeia 2010.The fast dissolving film was disintegrated in water within 30 s with reconstituted nanosuspensions particle size of 280.69 ± 11.57 rim, which was similar to that of drug nanosuspensions, indicating a good redispersibility of the fast dissolving film.Result of X-ray diffraction showed that HPE in the fast dissolving film was in the amorphous state.In the in vitro dissolution test, the fast dissolving film containing HPE nanoparticles showed an increased dissolution velocity markedly.The result revealed that the fast dissolving film containing drug nanoparticles may provide a potential opportunity in transforming drug nanosuspensions into a solid dosage form as well as enhancing the dissolution rate of poorly water-soluble drugs.
其他文献
本研究以灯盏乙素为模型药,研究自乳化给药系统(SEDDS)的常用辅料对多药耐药相关蛋白2(MRP2)抑制作用的剂量依赖性和协同效应.基于以前的研究结果,选取10种具有降低灯盏乙素外排作用的辅料和6种对MRP2有抑制作用的辅料,分别进行了Caco-2细胞模型研究、MRP2膜囊转运研究和ATP酶活性评价研究.同时,以对MRP2抑制作用最强的Cremophor(R) EL为中心,研究比较其它辅料与其联合
由中药葛根中提取而来的葛根素目前在临床上广泛用于心血管疾病的治疗.但由于其水溶性差和注射给药所带来的不良反应,目前迫切需要一种技术来用于葛根素口服给药制剂的开发.现如今,纳米结晶技术已慢慢成为难溶性药物口服制剂开发的首选技术.在本研究中,分别采用高剪切分散法和高压均质法来制备粒径分别为1875.6 nm、525.8 nm的葛根素微米结晶和纳米结晶,并考察了不同粒径的制剂对于药物药动学的影响.同时采
目的：优化戊己双层片的处方,探讨中药复方多组分同步释放的可能性.方法：根据3种提取物的溶解度差异,将其分成两组,分别为白芍提取物组成的B层缓释层,黄连提取物、吴茱萸提取物组成的Hw层缓释层;采用正交试验设计,通过综合评分法分别优选B层、HW层的处方,相似因子f2评价盐酸小檗碱、芍药苷、吴茱萸两碱释放的同步性.结果：B缓释层的最佳处方为:取白芍提取物43mg,加入35％的EC20cp,2％的PVPK
目的：确定槐定碱热敏脂质体最佳处方及制备工艺.方法：以热敏脂质体分别于37℃、43℃累积释药百分率为评价指标,采用design-expert软件进行中心复合设计,建立各指标与因素之间的数学关系,通过效应面法优化处方工艺条件,通过验证性实验进行预测分析.结果：中心优化设计考察得最佳处方工艺条件:脂药比为17.80,DPPC/MSPC为9.50制得的脂质体在37℃时释药达到4.30％,43℃释药79.
红景天苷(salidroside,Sal)是蔷薇目景天科红景天属(Rhodiola)植物的主要有效成分,具有较好的抗肿瘤活性.Sal对肿瘤组织缺乏选择性,且其高度的水溶性也不利于肿瘤细胞的高效摄取,因此限制了其作为抗癌药物在临床上的应用.本文采用复乳法制备红景天苷的新型递药系统即纳脂体(Sal-LPNPs),以实现水溶性极强的红景天苷的高效装载并增强其抗癌活性.以包封率、粒径、电位为评价指标,通过
课题组前期研究发现,蜣螂壳聚糖在成膜性、耐酸性、耐酶性、生物粘附性、流变性、重金属残留量等22个方面优于市售医药级虾蟹壳聚糖,适合作为酶触发型生物粘附结肠定位给药载体.采用氧化显色法、氧化-HPLC法、核磁共振波谱、热分析、元素分析、紫外-可见分光法等对蜣螂壳聚糖进行结构研究,发现蜣螂壳聚糖中含有10％左右的真黑色素.通过体外模拟合成与蜣螂甲壳素酶水解产物的分析,初步发现真黑色素与蜣螂甲壳素的构成
目的:比较栀子中四种环烯醚萜类成分抗血管性痴呆的活性大小,明确栀子抗血管性痴呆的物质基础,为栀子的进一步开发提供依据.方法:采用大鼠双侧颈总动脉结扎模型模拟临床上的血管性痴呆,经口服给予京尼平苷、京尼平苷酸、山栀子苷及京尼平,分别从行为学、形态学,比较四种环烯醚萜类成分对血管性痴呆的治疗效果.结果:行为学实验结果表明:在改善模型大鼠的学习能力方面,京尼平苷、京尼平苷酸及京尼平均能降低模型大鼠的逃避
目的：建立一种检测紫杉醇长循环热敏脂质体中溶血磷脂含量的方法,考察紫杉醇长循环热敏脂质体中的溶血磷脂含量及体外溶血性.方法：采用八烷基键合硅胶色谱柱(Vensuil XBP C8,4.6*250mm,5μm),流动相体系为甲醇-0.1 moL·L-1醋酸胺缓冲液(pH4.8),梯度洗脱,电喷雾检测器.结果：本方法的检测限为4ng,定量限为12ng,峰面积与浓度在1.5μg·mL-1-50μg·mL
目的：明确中药枳壳炮制前后的成分变化;分离、鉴定主要变化成分并开展其药效试验,揭示其药效作用机制以达到阐述枳壳的炮制机理.方法：采用高效液相色谱指纹图谱分离分析技术对枳壳生品及麸炒品进行分析比较,找寻主要差异成分,对其进行分离、鉴定;采用正常小鼠小肠推进试验、体外AchE活力测定及小鼠离体小肠平滑肌试验对所得主要差异成分的药效及其作用机制进行评价.结果：枳壳生品与麸炒品主要差异成分经鉴定为葡萄内酯
The phospholipid-bile salts-mixed micelles (PL-BS-MMs) are potent carriers used for oral absorption of drugs that are poorly soluble in water; however, there are many limitations associated with liqui